Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiaki Yoshikawa

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Journal of Hepatocellular Carcinoma|August 11, 2016
Critical analysis of the potential of targeting GPC3 in hepatocellular carcinomaKazuya Ofuji, Keigo Saito, Toshiaki Yoshikawa, et al.
Human Vaccines & Immunotherapeutics|February 16, 2013
Peptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategyDaisuke Nobuoka, Toshiaki Yoshikawa, Toshiyoshi Fujiwara, et al.
Oncoimmunology|December 18, 2012
A glypican-3-derived peptide vaccine against hepatocellular carcinomaYu Sawada, Mayuko Sakai, Toshiaki Yoshikawa, et al.
Frontiers in Oncology|April 27, 2019
Next-Generation Cancer Immunotherapy Targeting Glypican-3Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, et al.
Human Vaccines & Immunotherapeutics|February 28, 2013
Peptide vaccines for hepatocellular carcinomaDaisuke Nobuoka, Toshiaki Yoshikawa, Yu Sawada, et al.
International Journal of Oncology|September 6, 2014
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapyToshiaki Yoshikawa, Masashi Takahara, Mai Tomiyama, et al.
The Journal of Surgical Research|June 20, 2008
Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancerToshiaki Yoshikawa, Hiroaki Saito, Tomohiro Osaki, et al.
International Journal of Oncology|October 31, 2014
Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytesYu Sawada, Toshiaki Yoshikawa, Manami Shimomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancerTomohiro Osaki, Hiroaki Saito, Toshiaki Yoshikawa, et al.
International Journal of Oncology|January 29, 2013
Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptideTatsuaki Iwama, Kazutaka Horie, Toshiaki Yoshikawa, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Journal of Hepatocellular Carcinoma|August 11, 2016
Critical analysis of the potential of targeting GPC3 in hepatocellular carcinomaKazuya Ofuji, Keigo Saito, Toshiaki Yoshikawa, et al.
Human Vaccines & Immunotherapeutics|February 16, 2013
Peptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategyDaisuke Nobuoka, Toshiaki Yoshikawa, Toshiyoshi Fujiwara, et al.
Oncoimmunology|December 18, 2012
A glypican-3-derived peptide vaccine against hepatocellular carcinomaYu Sawada, Mayuko Sakai, Toshiaki Yoshikawa, et al.
Frontiers in Oncology|April 27, 2019
Next-Generation Cancer Immunotherapy Targeting Glypican-3Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, et al.
Human Vaccines & Immunotherapeutics|February 28, 2013
Peptide vaccines for hepatocellular carcinomaDaisuke Nobuoka, Toshiaki Yoshikawa, Yu Sawada, et al.
International Journal of Oncology|September 6, 2014
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapyToshiaki Yoshikawa, Masashi Takahara, Mai Tomiyama, et al.
The Journal of Surgical Research|June 20, 2008
Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancerToshiaki Yoshikawa, Hiroaki Saito, Tomohiro Osaki, et al.
International Journal of Oncology|October 31, 2014
Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytesYu Sawada, Toshiaki Yoshikawa, Manami Shimomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancerTomohiro Osaki, Hiroaki Saito, Toshiaki Yoshikawa, et al.
International Journal of Oncology|January 29, 2013
Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptideTatsuaki Iwama, Kazutaka Horie, Toshiaki Yoshikawa, et al.
Pageof 6